We are live on
!
Find out more
Level Four Advisory Services Portfolio holdings
AUM
$3.54B
Turnover
13.95%
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
-2.89%
1 Year Est. Return
+37.12%
3 Year Est. Return
+92.23%
5 Year Est. Return
+115.57%
10 Year Est. Return
–
AUM
$1.55B
AUM Growth
-$113M
(-6.8%)
Cap. Flow
-$51.6M
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
22.79%
Holding
882
New
80
Increased
269
Reduced
359
Closed
123
Avg Time Held Equity + Options
2.7
years
Top 10 Avg Time Held Equity + Options
1.8
years
Top 20 Avg Time Held Equity + Options
1.9
years
Avg Time Held Equity only
2.7
years
Top 10 Avg Time Held Equity only
1.8
years
Top 20 Avg Time Held Equity only
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Level Four Large Cap Growth Active ETF
LGRO
|
+$49.8M |
| 2 |
Salesforce
CRM
|
+$7.12M |
| 3 |
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
|
+$5.39M |
| 4 |
VanEck Morningstar Wide Moat ETF
MOAT
|
+$4.67M |
| 5 |
Invesco S&P MidCap Momentum ETF
XMMO
|
+$3.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$49.5M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$19.8M |
| 3 |
AbbVie
ABBV
|
+$6.73M |
| 4 |
Abbott
ABT
|
+$6.2M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$5.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.94% |
| 2 | Technology | 17.68% |
| 3 | Healthcare | 7.75% |
| 4 | Financials | 7.02% |
| 5 | Consumer Staples | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Sachem Capital Corp
SACH
$39.8M
| $59K | ﹤0.01% |
16,700
| – | – |
2023 Q2
1 quarter
|
|
727
Denison Mines
DNN
$2.09B
| $54K | ﹤0.01% |
32,743
-6,175
| -16% | -$8.54K |
2021 Q4
7 quarters
|
|
728
Equinox Gold
EQX
$12.9B
| $45.9K | ﹤0.01% |
10,855
-444
| -4% | -$2.14K |
2023 Q1
2 quarters
|
|
|
MIN
729
Aberdeen Intermediate Income Fund
MIN
$267M
| $30.4K | ﹤0.01% |
1,892
| – | – |
2022 Q4
3 quarters
|
|
730
Mereo BioPharma
MREO
$48.5M
| $25.8K | ﹤0.01% |
20,000
| – | – |
2022 Q1
6 quarters
|
|
731
DELISTED
T2 Biosystems, Inc
TTOO
| $24.3K | ﹤0.01% |
+1,100
| New | +$28.7K |
2023 Q3
0 quarters
|
|
732
Virgin Galactic
SPCE
$374M
| $23.6K | ﹤0.01% |
655
-14
| -2% | -$835 |
2023 Q2
1 quarter
|
|
733
DELISTED
Tellurian Inc.
TELL
| $23.3K | ﹤0.01% |
20,100
+100
| +0.5% | +$136 |
2023 Q1
2 quarters
|
|
734
RenovoRx
RNXT
$53.3M
| $19.9K | ﹤0.01% |
15,000
| – | – |
2023 Q1
2 quarters
|
|
735
Immunic
IMUX
$93.9M
| $17.3K | ﹤0.01% |
1,179
| – | – |
2023 Q1
2 quarters
|
|
736
Gevo
GEVO
$294M
| $11.9K | ﹤0.01% |
10,000
| – | – |
2022 Q4
3 quarters
|
|
737
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
| $7.1K | ﹤0.01% |
+2,381
| New | +$4.35K |
2023 Q3
0 quarters
|
|
|
BINI
738
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2023 Q3
0 quarters
|
|
739
CALL
Amazon
AMZN
$2.71T
| $6.3K | ﹤0.01% |
100
| – | – |
2023 Q1
2 quarters
|
|
740
Workhorse Group
WKHS
$29.5M
| $5.53K | ﹤0.01% |
4
| – | – |
2016 Q4
27 quarters
|
|
741
Cheer Holding
CHR
$3.49M
| $5.43K | ﹤0.01% |
+9
| New | +$6.3K |
2023 Q3
0 quarters
|
|
742
China SXT Pharmaceuticals
SXTC
$94.1K
| – | – |
0
| – | – |
2023 Q3
0 quarters
|
|
743
Outlook Therapeutics
OTLK
$123M
| $5.24K | ﹤0.01% |
+1,185
| New | +$26.2K |
2023 Q3
0 quarters
|
|
|
NAVB
744
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $4.98K | ﹤0.01% |
+55,555
| New | +$5.16K |
2023 Q3
0 quarters
|
|
745
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
| $4.86K | ﹤0.01% |
+675
| New | +$14K |
2023 Q3
0 quarters
|
|
746
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $4.63K | ﹤0.01% |
+26,441
| New | +$32.9K |
2023 Q3
0 quarters
|
|
747
Avalo Therapeutics
AVTX
$612M
| $4.36K | ﹤0.01% |
+151
| New | +$6.75K |
2023 Q3
0 quarters
|
|
748
CALL
L3Harris
LHX
$45.4B
| $4.08K | ﹤0.01% |
+300
| New | +$55.2K |
2023 Q3
0 quarters
|
|
749
DELISTED
China Liberal Education Holdings
CLEU
| $4.06K | ﹤0.01% |
+1
| New | +$18.2K |
2023 Q3
0 quarters
|
|
|
AVX
750
Avax One Technology Ltd
AVX
$33.4M
| – | – |
0
| – | – |
2023 Q3
0 quarters
|
|
Similar funds
Level Four Advisory Services's Q3 2023 Portfolio in Review
As of Q3 2023, Level Four Advisory Services held 882 positions worth $1.55B, down 6.8% from $1.66B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Level Four Advisory Services withdrew a net $51.6M in Q3 2023, closing 123 positions and reducing 359 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $49.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Level Four Advisory Services opened a new position in Level Four Large Cap Growth Active ETF worth $48.1M.
- Level Four Advisory Services's largest Q3 2023 buy was Level Four Large Cap Growth Active ETF: 1,973,520 shares worth $48.1M.
- Level Four Advisory Services added most to State Street SPDR S&P 600 Small Cap Growth ETF in Q3 2023, an estimated $5.39M increase.
- Level Four Advisory Services's biggest Q3 2023 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $19.8M.
- Level Four Advisory Services fully exited Invesco QQQ Trust in Q3 2023, selling an estimated $49.5M.
- Level Four Advisory Services's ten largest holdings make up 23% of its $1.55B portfolio in Q3 2023.
- Level Four Advisory Services opened 80 new positions and closed 123 in Q3 2023.
- Level Four Advisory Services's portfolio value fell 6.8% quarter-over-quarter to $1.55B.
Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.